Who makes Base Dose EBOV GP Vaccine?

Base Dose EBOV GP Vaccine is developed by Novavax.

What development phase is Base Dose EBOV GP Vaccine in?

Base Dose EBOV GP Vaccine is in Phase 1.

Last reviewed 2026-05-15 · How we verify

Base Dose EBOV GP Vaccine

Novavax · Phase 1 active Biologic

At a glance

Generic name	Base Dose EBOV GP Vaccine
Sponsor	Novavax
Modality	Biologic
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Base Dose EBOV GP Vaccine CI brief — competitive landscape report
Base Dose EBOV GP Vaccine updates RSS · CI watch RSS
Novavax portfolio CI